Different FGFR2 haplotypes such as GTGT in African-Americans and GTG in north Indians have been reported to increase BC risk (Siddiqui et al., 2014; Barnholtz-Sloan et al., 2010). This evidence concerns the gene FGFR2 and breast cancer.